| Antigen |
HIF-1 alpha |
| Applications |
Flow Cytometry, Immunocytochemistry, Immunofluorescence, Functional Assay |
| Classification |
Monoclonal |
| Clone |
HIF1A-84 |
| Conjugate |
Unconjugated |
| Dilution |
Flow Cytometry 0.5-1ug/million cells, Immunocytochemistry/Immunofluorescence 0.5-1ug/ml, Functional |
| Formulation |
PBS with 0.05% BSA. with 0.05% Sodium Azide |
| Gene Accession No. |
Q16665 |
| Gene Alias |
ARNT-interacting protein, Basic-helix-loop-helix-PAS protein MOP1, BHLHE78, Class E basic helix-loop-helix protein 78, HIF-1 alpha, HIF1A, HIF-1-alpha, HIF1-alpha, hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcriptionfactor), hypoxia-inducible factor 1-alpha, Member of PAS protein 1, member of PAS superfamily 1, MOP1HIF1-ALPHA, PAS domain-containing protein 8, PASD8alpha subunit (basic helix-loop-helix transcriptionfactor) |
| Gene Symbols |
HIF1A |
| Host Species |
Mouse |
| Immunogen |
Recombinant human HIF1 alpha protein |
| Molecular Weight of Antigen |
93 kDa |
| Purification Method |
Protein A purified |
| Quantity |
0.2 mg |
| Regulatory Status |
RUO |
| Research Discipline |
Angiogenesis, Autophagy, Cancer, Cellular Markers, Chromatin Research, HIF Target Genes, Hypoxia, mTOR Pathway, Transcription Factors and Regulators |
| Primary or Secondary |
Primary |
| Gene ID (Entrez) |
3091 |
| Test Specificity |
HIF1 (hypoxia-inducible factor 1), a heterodimeric transcription factor complex central to cellular response to hypoxia, consists of two subunits (HIF-1 alpha and HIF-1 beta) which are basic helix-loop-helix proteins of the PAS (Per, ARNT, Sim) family. Expression of HIF-1 alpha protein is regulated by cellular oxygen level alterations as well as in oxygen-independent manner via different cytokines (through the PI3K-AKT-mTOR pathway), growth factors, oncogenic activation, or loss of tumor suppressor function etc. In normoxic cells, HIF-1 alpha is proline hydroxylated leading to a conformational change that promotes its binding to the VLH (von Hippel Lindau) protein E3 ligase complex; ubiquitination and followed by rapid proteasomal degradation. Hypoxia as well as chemical hydroxylase inhibitors (desferrioxamine, cobalt etc.) inhibit HIF-1 alpha degradation and lead to its accumulation in the cells, whereas, contrastingly, HIF-1 beta/ARNT (AhR nuclear translocator) remains stable under both conditions. Besides their critical role in hypoxic response, HIF1s regulates the transcription of genes responsible for angiogenesis, erythropoiesis/iron-metabolism, glucose metabolism, cell proliferation/survival, adipogenesis, carotid body formation, B lymphocyte development and immune reactions. |
| Target Species |
Human |
| Content And Storage |
Store at 4C. |
| Form |
Purified |
| Isotype |
IgG2b κ |
|
Show More
Show Less
|
|